Nicholas Investment Partners, LP Adma Biologics, Inc. Transaction History
Nicholas Investment Partners, LP
- $900 Million
- Q3 2024
A detailed history of Nicholas Investment Partners, LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 283,696 shares of ADMA stock, worth $5.4 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
283,696Holding current value
$5.4 Million% of portfolio
0.63%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
317Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$355 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$345 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$248 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$240 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$164 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.74B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...